Vitamin Blue, Inc.
Other OTCTotal Valuation
Vitamin Blue, Inc. carries a market capitalization of 78,341.00, placing it among publicly traded companies globally.
| Market Cap | 78,341.00 |
| Enterprise Value | N/A |
Share Statistics
Vitamin Blue, Inc. currently has 738.41M shares outstanding.
| Shares Outstanding | 738.41M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 9.41, and the price-to-book ratio stands at -0.67.
| PE Ratio | N/A |
| PS Ratio | 9.41 |
| PB Ratio | -0.67 |
| P/TBV Ratio | -1.55 |
| P/FCF Ratio | -18.89 |
| P/OCF Ratio | -18.89 |
Financial Position
Vitamin Blue, Inc. maintains a current ratio of 0.04, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.04 |
| Quick Ratio | 0.02 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -0.42 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -2,530.26 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -11.54 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.77 |
Stock Price Statistics
Vitamin Blue, Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Vitamin Blue, Inc. generated 146,214.00 in revenue and converted that into -1.28M in net income, yielding earnings per share of 0.00. EBITDA reached -112,373.00, while operating income came in at -113,749.00.
| Revenue | 146,214.00 |
| Gross Profit | 60,234.00 |
| Operating Income | -113,749.00 |
| Pretax Income | -1.28M |
| Net Income | -1.28M |
| EBITDA | -112,373.00 |
| EBIT | -113,749.00 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
Total book value stands at -2.04M, with working capital of -900,772.00 providing operational flexibility.
| Cash & Cash Equivalents | 2,522.00 |
| Total Debt | N/A |
| Net Debt | 296,843.00 |
| Equity (Book Value) | -2.04M |
| Book Value Per Share | 0.00 |
| Working Capital | -900,772.00 |
Cash Flow
Vitamin Blue, Inc. produced -72,825.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -72,825.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -72,825.00 |
| FCF Per Share | 0.00 |
Margins
Vitamin Blue, Inc. operates with a gross margin of 41.20, reflecting its pricing power and cost economics. The operating margin of -77.80 and net profit margin of -876.13 provide insight into operational efficiency.
| Gross Margin | 41.20 |
| Operating Margin | -77.80 |
| Pretax Margin | -876.13 |
| Profit Margin | -876.13 |
| EBITDA Margin | -76.86 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -5.45 |
| FCF Yield | -5.29 |
Scores
Vitamin Blue, Inc. posts an Altman Z-Score of -96.65, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -96.65 |